{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:06:34Z","timestamp":1779887194484,"version":"3.53.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T00:00:00Z","timestamp":1461542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154256","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T13:28:15Z","timestamp":1461590895000},"page":"e0154256","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Abnormal IGF-Binding Protein Profile in the Bone Marrow of Multiple Myeloma Patients"],"prefix":"10.1371","volume":"11","author":[{"given":"Liesbeth","family":"Bieghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malene","family":"Brohus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida B.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Abildgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00f8gsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans E.","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl A.","family":"Conover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"De Bruyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Vanderkerken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-2481","authenticated-orcid":true,"given":"Michael T.","family":"Overgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Nyegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,4,25]]},"reference":[{"issue":"19","key":"ref1","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"AC Sprynski","year":"2009","journal-title":"Blood"},{"issue":"7391","key":"ref2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"issue":"5","key":"ref3","first-page":"706","article-title":"CD221 (IGF-1R) is aberrantly expressed in multiple myeloma, in relation to disease severity","volume":"90","author":"R Bataille","year":"2005","journal-title":"Haematologica"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/sj.leu.2403997","article-title":"IGF-1R is overexpressed in poor-prognostic subtypes of multiple myeloma","volume":"20","author":"WJ Chng","year":"2006","journal-title":"Leuk Off J Leuk Soc Am Leuk Res Fund, UK"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2002-05-1406","article-title":"Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor","volume":"100","author":"T Standal","year":"2002","journal-title":"Blood"},{"issue":"25","key":"ref6","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1182\/blood-2012-03-417253","article-title":"Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium","volume":"120","author":"BM Birmann","year":"2012","journal-title":"Blood"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood-2010-04-279760","article-title":"Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration","volume":"117","author":"J Moreaux","year":"2011","journal-title":"Blood"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/leu.2011.4","article-title":"Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myeloma","volume":"25","author":"P Moreau","year":"2011","journal-title":"Leukemia"},{"issue":"13","key":"ref9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/jnci\/djs258","article-title":"Insulin-like growth factor receptor inhibitors: baby or the bathwater?","volume":"104","author":"D Yee","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"ref10","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.18632\/oncotarget.1933","article-title":"The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic","volume":"5","author":"L Bieghs","year":"2014","journal-title":"Oncotarget"},{"issue":"16","key":"ref11","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1182\/blood-2011-10-386789","article-title":"Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma","volume":"120","author":"DJ Kuhn","year":"2012","journal-title":"Blood"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrc3720","article-title":"IGF binding proteins in cancer: mechanistic and clinical insights","volume":"14","author":"RC Baxter","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"22","key":"ref13","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"O Landgren","year":"2009","journal-title":"Blood"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-014-0105-1","article-title":"Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma","volume":"8","author":"A Bolomsky","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1210\/jcem.86.2.7241-1","article-title":"CCN proteins are distinct from, and should not be considered members of, the insulin-like growth factor-binding protein superfamily","volume":"86","author":"GR Grotendorst","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/ejh.12125","article-title":"Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration","volume":"91","author":"IB Kristensen","year":"2013","journal-title":"Eur J Haematol"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI116272","article-title":"Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies","volume":"91","author":"CA Conover","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/en.2010-1095","article-title":"Overexpression of pregnancy-associated plasma protein-A in ovarian cancer cells promotes tumor growth in vivo","volume":"152","author":"HB Boldt","year":"2011","journal-title":"Endocrinology"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X","article-title":"Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation","volume":"13","author":"H Yu","year":"1999","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo.134.1.7506203","article-title":"Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells","volume":"134","author":"R Okazaki","year":"1994","journal-title":"Endocrinology"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1677\/joe.1.06164","article-title":"IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells","volume":"186","author":"JM Fleming","year":"2005","journal-title":"J Endocrinol"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1152\/ajpendo.00648.2007","article-title":"Insulin-like growth factor-binding proteins and bone metabolism","volume":"294","author":"C a Conover","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.bone.2005.07.024","article-title":"Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth","volume":"37","author":"MC Fisher","year":"2005","journal-title":"Bone"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1095\/biolreprod.102.007609","article-title":"Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation","volume":"68","author":"P Monget","year":"2003","journal-title":"Biol Reprod"},{"key":"ref25","article-title":"Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment","author":"C Bret","year":"2011","journal-title":"Exp Hematol"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/JME-13-0184","article-title":"Heparin-binding mechanism of the IGF2\/IGF-binding protein 2 complex","volume":"52","author":"J Lund","year":"2014","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1038\/bjc.2014.232","article-title":"Exogenous administration of protease-resistant, non-matrix-binding IGFBP-2 inhibits tumour growth in a murine model of breast cancer","volume":"110","author":"C-L Soh","year":"2014","journal-title":"Br J Cancer"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/sj.bjc.6605141","article-title":"Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer","volume":"101","author":"AJ Ryan","year":"2009","journal-title":"Br J Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T20:55:21Z","timestamp":1567803321000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154256"}},"subtitle":[],"editor":[{"given":"Claire M.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,25]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154256","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,25]]}}}